Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Bioprinting on-chip microphysiological models of humanized kidney tubulointerstitium

Descrizione del progetto

Un modello biostampato del rene umano

La lesione renale acuta causata da droghe o virus può portare alla malattia renale cronica. Attualmente, mancano modelli in vitro adatti e rilevanti per lo studio di queste condizioni patologiche. Il progetto BIRDIE, finanziato dall’UE, mira ad affrontare questa limitazione sviluppando un modello tubulointerstiziale (TI) in vitro 3D di rene umano a partire da cellule umane primarie e da cellule staminali pluripotenti indotte. Gli scienziati impiegheranno tecnologie di biostampa e di organo su chip per sviluppare il modello TI, che sarà molto fedele alla fisiologia del rene naturale. Si ritiene che il modello BIRDIE contribuirà allo studio di malattie legate ai reni e alla selezione di terapie paziente-specifiche.

Obiettivo

Eight hundred and fifty million people worldwide are currently affected by chronic kidney disease (CKD), which is also the 11th leading cause of mortality worldwide. CKD can occur from a multitude of causes including diabetes and high-blood pressure. Moreover, recent clinical and experimental studies have shown that CKD is closely interconnected with acute kidney injury (AKI) as well. Currently available in vitro models show limited relevance to study AKI, especially drug- and virus- induced AKI, due to the poor functionality and relevance compared to a diseased human tissue. BIRDIE aims at developing three-dimensional (3D) in vitro human renal tubulointerstitium (TI) models to enable viral infection and nephrotoxicity studies while creating a robust platform to address other diseases and treatment innovations in the future. Two enabling technologies, bioprinting and organ-on-chip, will be combined to build a microphysiological relevant TI model. Primary human cells and induced pluripotent stem cells will be used to generate kidney models, and combined with the aforementioned techniques model envisioning a reliable screening platform for future patient specific therapies. Our ambition is to create a new 3D renal in vitro model allowing an unprecedented degree of mimicry and function compared to a human kidney. While developing the model focusing on the applications mentioned before, our goal is to make it broadly applicable to the multitude of kidney-related diseases.

Invito a presentare proposte

H2020-FETOPEN-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-FETOPEN-2018-2019-2020-01

Meccanismo di finanziamento

RIA - Research and Innovation action

Coordinatore

UNIVERSITEIT MAASTRICHT
Contribution nette de l'UE
€ 1 057 150,00
Indirizzo
MINDERBROEDERSBERG 4
6200 MD Maastricht
Paesi Bassi

Mostra sulla mappa

Regione
Zuid-Nederland Limburg (NL) Zuid-Limburg
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 057 150,00

Partecipanti (4)